Cardiff Oncology, Inc. · NASDAQ:CRDF
BlackRock, Inc.'s stake in Cardiff Oncology, Inc. fell to 4.30% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc.'s stake in Cardiff Oncology, Inc. fell to 4.30%, 2,840,909 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 4.30%
- Shares
- 2,840,909
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.30% | 2,840,909 |
Source
Related
- Cardiff Oncology, Inc.
- BlackRock, Inc.
- Cardiff Oncology, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G · BlackRock, Inc. · Apr 23, 2025
- Form 4 · Pace Gary W · Jul 16, 2026
- Form 4 · Mohindru Mani · Jul 16, 2026
- Form 4 · Mohindru Mani · Jun 22, 2026
- Form 4 · Pace Gary W · Jun 22, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026